DENTSPLY SIRONA (NASDAQ:XRAY) Lowered to Hold Rating by StockNews.com

StockNews.com downgraded shares of DENTSPLY SIRONA (NASDAQ:XRAY) from a buy rating to a hold rating in a research note published on Tuesday morning.

Several other brokerages also recently weighed in on XRAY. Leerink Partners downgraded DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research note on Thursday, November 7th. Barrington Research reduced their price objective on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a research report on Friday, November 8th. Leerink Partnrs lowered shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 7th. Robert W. Baird reduced their price target on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a research report on Friday, November 8th. Finally, Needham & Company LLC lowered their price objective on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a report on Friday, October 25th. Seven investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $29.50.

DENTSPLY SIRONA Stock Performance

Shares of NASDAQ XRAY opened at $18.64 on Tuesday. The company has a market capitalization of $3.71 billion, a PE ratio of -9.02, a price-to-earnings-growth ratio of 1.85 and a beta of 1.02. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The company’s fifty day moving average price is $23.54 and its 200 day moving average price is $25.20. DENTSPLY SIRONA has a 1 year low of $17.21 and a 1 year high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.48 by $0.02. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The business had revenue of $951.00 million for the quarter, compared to analyst estimates of $939.10 million. During the same period in the prior year, the company posted $0.49 EPS. The company’s revenue for the quarter was up .4% on a year-over-year basis. On average, research analysts predict that DENTSPLY SIRONA will post 1.84 earnings per share for the current year.

Institutional Investors Weigh In On DENTSPLY SIRONA

Large investors have recently made changes to their positions in the stock. UMB Bank n.a. grew its holdings in DENTSPLY SIRONA by 430.3% in the 3rd quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock valued at $25,000 after buying an additional 753 shares in the last quarter. Capital Performance Advisors LLP purchased a new stake in shares of DENTSPLY SIRONA in the third quarter valued at about $27,000. LRI Investments LLC increased its position in DENTSPLY SIRONA by 82.7% during the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock worth $31,000 after purchasing an additional 564 shares during the last quarter. Rothschild Investment LLC purchased a new position in DENTSPLY SIRONA during the second quarter worth about $32,000. Finally, Kennebec Savings Bank acquired a new position in DENTSPLY SIRONA in the 3rd quarter valued at about $35,000. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.